An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS
-
Published:2022-12-10
Issue:4
Volume:32
Page:1199-1208
-
ISSN:0962-9343
-
Container-title:Quality of Life Research
-
language:en
-
Short-container-title:Qual Life Res
Author:
Svedbom AxelORCID, Borgstöm Fredrik, Hernlund Emma, Alekna Vidmantas, Bianchi Maria Luisa, Clark Patricia, Diaz-Curiel Manuel, Dimai Hans Peter, Jürisson Mikk, Lesnyak Olga, McCloskey Eugene, Sanders Kerrie M., Silverman Stuart, Tamulaitiene Marija, Thomas Thierry, Tosteson Anna N. A., Jönsson Bengt, Kanis John A.
Abstract
Abstract
Introduction
EQ-5D-3L preference-based value sets are predominately based on hypothetical health states and derived in cross-sectional settings. Therefore, we derived an experience-based value set from a prospective observational study.
Methods
The International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) was a multinational study on fragility fractures, prospectively collecting EQ-5D-3L and Time trade-off (TTO) within two weeks after fracture (including pre-fracture recall), and at 4, 12, and 18 months thereafter. We derived an EQ-5D-3L value set by regressing the TTO values on the ten impairment levels in the EQ-5D-3L. We explored the potential for response shift and whether preferences for domains vary systematically with prior impairment in that domain. Finally, we compared the value set to 25 other EQ-5D-3L preference-based value sets.
Results
TTO data were available for 12,954 EQ-5D-3L health states in 4683 patients. All coefficients in the value set had the expected sign, were statistically significant, and increased monotonically with severity of impairment. We found evidence for response shift in mobility, self-care, and usual activities. The value set had good agreement with the only other experience- and preference-based value set, but poor agreement with all hypothetical value sets.
Conclusions
We present an experience- and preference-based value set with high face validity. The study indicates that response shift may be important to account for when deriving value sets. Furthermore, the study suggests that perspective (experienced versus hypothetical) is more important than country setting or demographics for valuation of EQ-5D-3L health states.
Funder
Amgen Eli Lilly and Company Medtronic Novartis Sanofi Servier Pfizer Merck Pty Ltd the National Health and Medical Research Council Hauptverband der österreichischen Soziaversicherungs-träger Austrian Society for Bone and Mineral Research Merck Sharp and Dohme Servier GmbH Medtronic GmbH Amgen GmbH Novartis GmbH Nycomed GmbH Roche GmbH Sanofi-Aventis GmbH Daiichi-Sankyo GmbH CONACyT Lithuania National Osteoporosis Center Ingenix Pharmaceutical Services Medtronic Spine LLC Estonian Science Foundation Estonian Ministry of Education and Research Russian Osteoporosis Association Karolinska Institute
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference24 articles.
1. Devlin, N., Parkin, D., & Janssen, B. (2020). Methods for analysing and reporting EQ-5D Data. Springer. 2. Oppe, M., Devlin, N. J., & Szende, A. (2007). EQ-5D value sets: Inventory, comparative review and user guide. Springer. 3. Lamers, L. M., Stalmeier, P. F., Krabbe, P. F., & Busschbach, J. J. (2006). Inconsistencies in TTO and VAS values for EQ-5D health states. Medical Decision Making, 26(2), 173–181. 4. Lugnér, A. K., & Krabbe, P. F. M. (2020). An overview of the time trade-off method: Concept, foundation, and the evaluation of distorting factors in putting a value on health. Expert Review of Pharmacoeconomics & Outcomes Research, 20(4), 331–342. 5. Stamuli, E. (2011). Health outcomes in economic evaluation: Who should value health? British Medical Bulletin, 97, 197–210.
|
|